Credit Suisse’s Actinium Pharmaceuticals ATNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1
| Closed | -$11 | – | 3278 |
|
|
2022
Q4 | $11 | Hold |
1
| – | – | ﹤0.01% | 3706 |
|
|
2022
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 4018 |
|
|
2022
Q2 | $0 | Buy |
+1
| New | – | ﹤0.01% | 3901 |
|
|
2018
Q3 | – | Sell |
-43,674
| Closed | -$839K | – | 3286 |
|
|
2018
Q2 | $839K | Buy |
43,674
+16,667
| +62% | +$320K | ﹤0.01% | 2701 |
|
|
2018
Q1 | $296K | Hold |
27,007
| – | – | ﹤0.01% | 3153 |
|
|
2017
Q4 | $538K | Buy |
27,007
+2,007
| +8% | +$40K | ﹤0.01% | 2912 |
|
|
2017
Q3 | $431K | Buy |
+25,000
| New | +$431K | ﹤0.01% | 3102 |
|